Industry Research Reports

Home > Reports > Service & Software > AI Drug Development- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

AI Drug Development- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-02-20

Pages: 119 Pages

Report ld: 4021868

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for AI Drug Development was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for AI Drug Development, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI Drug Development by region & country, by Type, and by Application.

The AI Drug Development market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Drug Development.

MARKET SEGMENTATION

By Company

Insilico Medicine
Cyclica
XtalPi Inc.
Exscientia Limited
AiCure, LLC
Atomwise
Biovista Inc.
Breg，Inc.
Numerate
Cloud Pharmaceuticals
IBM
NuMedii
BenevolentAI
Lam Therapeutics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Drug Design
Drug Synthesis
Other

Segment by Application

Tumor
Nervous System
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of AI Drug Development company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of AI Drug Development in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of AI Drug Development in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 AI Drug Development Product Introduction

1.2 Global AI Drug Development Market Size Forecast (2020-2031)

1.3 AI Drug Development Market Trends & Drivers

1.3.1 AI Drug Development Industry Trends

1.3.2 AI Drug Development Market Drivers & Opportunity

1.3.3 AI Drug Development Market Challenges

1.3.4 AI Drug Development Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global AI Drug Development Players Revenue Ranking (2024)

2.2 Global AI Drug Development Revenue by Company (2020-2025)

2.3 Key Companies AI Drug Development Manufacturing Base Distribution and Headquarters

2.4 Key Companies AI Drug Development Product Offered

2.5 Key Companies Time to Begin Mass Production of AI Drug Development

2.6 AI Drug Development Market Competitive Analysis

2.6.1 AI Drug Development Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by AI Drug Development Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Development as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Drug Design

3.1.2 Drug Synthesis

3.1.3 Other

3.2 Global AI Drug Development Sales Value by Type

3.2.1 Global AI Drug Development Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global AI Drug Development Sales Value, by Type (2020-2031)

3.2.3 Global AI Drug Development Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Tumor

4.1.2 Nervous System

4.1.3 Other

4.2 Global AI Drug Development Sales Value by Application

4.2.1 Global AI Drug Development Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global AI Drug Development Sales Value, by Application (2020-2031)

4.2.3 Global AI Drug Development Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global AI Drug Development Sales Value by Region

5.1.1 Global AI Drug Development Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global AI Drug Development Sales Value by Region (2020-2025)

5.1.3 Global AI Drug Development Sales Value by Region (2026-2031)

5.1.4 Global AI Drug Development Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America AI Drug Development Sales Value, 2020-2031

5.2.2 North America AI Drug Development Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe AI Drug Development Sales Value, 2020-2031

5.3.2 Europe AI Drug Development Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific AI Drug Development Sales Value, 2020-2031

5.4.2 Asia Pacific AI Drug Development Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America AI Drug Development Sales Value, 2020-2031

5.5.2 South America AI Drug Development Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa AI Drug Development Sales Value, 2020-2031

5.6.2 Middle East & Africa AI Drug Development Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions AI Drug Development Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions AI Drug Development Sales Value, 2020-2031

6.3 United States

6.3.1 United States AI Drug Development Sales Value, 2020-2031

6.3.2 United States AI Drug Development Sales Value by Type (%), 2024 VS 2031

6.3.3 United States AI Drug Development Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe AI Drug Development Sales Value, 2020-2031

6.4.2 Europe AI Drug Development Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe AI Drug Development Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China AI Drug Development Sales Value, 2020-2031

6.5.2 China AI Drug Development Sales Value by Type (%), 2024 VS 2031

6.5.3 China AI Drug Development Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan AI Drug Development Sales Value, 2020-2031

6.6.2 Japan AI Drug Development Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan AI Drug Development Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea AI Drug Development Sales Value, 2020-2031

6.7.2 South Korea AI Drug Development Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea AI Drug Development Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia AI Drug Development Sales Value, 2020-2031

6.8.2 Southeast Asia AI Drug Development Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia AI Drug Development Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India AI Drug Development Sales Value, 2020-2031

6.9.2 India AI Drug Development Sales Value by Type (%), 2024 VS 2031

6.9.3 India AI Drug Development Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Insilico Medicine

7.1.1 Insilico Medicine Profile

7.1.2 Insilico Medicine Main Business

7.1.3 Insilico Medicine AI Drug Development Products, Services and Solutions

7.1.4 Insilico Medicine AI Drug Development Revenue (US$ Million) & (2020-2025)

7.1.5 Insilico Medicine Recent Developments

7.2 Cyclica

7.2.1 Cyclica Profile

7.2.2 Cyclica Main Business

7.2.3 Cyclica AI Drug Development Products, Services and Solutions

7.2.4 Cyclica AI Drug Development Revenue (US$ Million) & (2020-2025)

7.2.5 Cyclica Recent Developments

7.3 XtalPi Inc.

7.3.1 XtalPi Inc. Profile

7.3.2 XtalPi Inc. Main Business

7.3.3 XtalPi Inc. AI Drug Development Products, Services and Solutions

7.3.4 XtalPi Inc. AI Drug Development Revenue (US$ Million) & (2020-2025)

7.3.5 XtalPi Inc. Recent Developments

7.4 Exscientia Limited

7.4.1 Exscientia Limited Profile

7.4.2 Exscientia Limited Main Business

7.4.3 Exscientia Limited AI Drug Development Products, Services and Solutions

7.4.4 Exscientia Limited AI Drug Development Revenue (US$ Million) & (2020-2025)

7.4.5 Exscientia Limited Recent Developments

7.5 AiCure, LLC

7.5.1 AiCure, LLC Profile

7.5.2 AiCure, LLC Main Business

7.5.3 AiCure, LLC AI Drug Development Products, Services and Solutions

7.5.4 AiCure, LLC AI Drug Development Revenue (US$ Million) & (2020-2025)

7.5.5 AiCure, LLC Recent Developments

7.6 Atomwise

7.6.1 Atomwise Profile

7.6.2 Atomwise Main Business

7.6.3 Atomwise AI Drug Development Products, Services and Solutions

7.6.4 Atomwise AI Drug Development Revenue (US$ Million) & (2020-2025)

7.6.5 Atomwise Recent Developments

7.7 Biovista Inc.

7.7.1 Biovista Inc. Profile

7.7.2 Biovista Inc. Main Business

7.7.3 Biovista Inc. AI Drug Development Products, Services and Solutions

7.7.4 Biovista Inc. AI Drug Development Revenue (US$ Million) & (2020-2025)

7.7.5 Biovista Inc. Recent Developments

7.8 Breg，Inc.

7.8.1 Breg，Inc. Profile

7.8.2 Breg，Inc. Main Business

7.8.3 Breg，Inc. AI Drug Development Products, Services and Solutions

7.8.4 Breg，Inc. AI Drug Development Revenue (US$ Million) & (2020-2025)

7.8.5 Breg，Inc. Recent Developments

7.9 Numerate

7.9.1 Numerate Profile

7.9.2 Numerate Main Business

7.9.3 Numerate AI Drug Development Products, Services and Solutions

7.9.4 Numerate AI Drug Development Revenue (US$ Million) & (2020-2025)

7.9.5 Numerate Recent Developments

7.10 Cloud Pharmaceuticals

7.10.1 Cloud Pharmaceuticals Profile

7.10.2 Cloud Pharmaceuticals Main Business

7.10.3 Cloud Pharmaceuticals AI Drug Development Products, Services and Solutions

7.10.4 Cloud Pharmaceuticals AI Drug Development Revenue (US$ Million) & (2020-2025)

7.10.5 Cloud Pharmaceuticals Recent Developments

7.11 IBM

7.11.1 IBM Profile

7.11.2 IBM Main Business

7.11.3 IBM AI Drug Development Products, Services and Solutions

7.11.4 IBM AI Drug Development Revenue (US$ Million) & (2020-2025)

7.11.5 IBM Recent Developments

7.12 NuMedii

7.12.1 NuMedii Profile

7.12.2 NuMedii Main Business

7.12.3 NuMedii AI Drug Development Products, Services and Solutions

7.12.4 NuMedii AI Drug Development Revenue (US$ Million) & (2020-2025)

7.12.5 NuMedii Recent Developments

7.13 BenevolentAI

7.13.1 BenevolentAI Profile

7.13.2 BenevolentAI Main Business

7.13.3 BenevolentAI AI Drug Development Products, Services and Solutions

7.13.4 BenevolentAI AI Drug Development Revenue (US$ Million) & (2020-2025)

7.13.5 BenevolentAI Recent Developments

7.14 Lam Therapeutics

7.14.1 Lam Therapeutics Profile

7.14.2 Lam Therapeutics Main Business

7.14.3 Lam Therapeutics AI Drug Development Products, Services and Solutions

7.14.4 Lam Therapeutics AI Drug Development Revenue (US$ Million) & (2020-2025)

7.14.5 Lam Therapeutics Recent Developments

8 Industry Chain Analysis

8.1 AI Drug Development Industrial Chain

8.2 AI Drug Development Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 AI Drug Development Sales Model

8.5.2 Sales Channel

8.5.3 AI Drug Development Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. AI Drug Development Market Trends

Table 2. AI Drug Development Market Drivers & Opportunity

Table 3. AI Drug Development Market Challenges

Table 4. AI Drug Development Market Restraints

Table 5. Global AI Drug Development Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global AI Drug Development Revenue Market Share by Company (2020-2025)

Table 7. Key Companies AI Drug Development Manufacturing Base Distribution and Headquarters

Table 8. Key Companies AI Drug Development Product Type

Table 9. Key Companies Time to Begin Mass Production of AI Drug Development

Table 10. Global AI Drug Development Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Development as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global AI Drug Development Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global AI Drug Development Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global AI Drug Development Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global AI Drug Development Sales Market Share in Value by Type (2020-2025)

Table 17. Global AI Drug Development Sales Market Share in Value by Type (2026-2031)

Table 18. Global AI Drug Development Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global AI Drug Development Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global AI Drug Development Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global AI Drug Development Sales Market Share in Value by Application (2020-2025)

Table 22. Global AI Drug Development Sales Market Share in Value by Application (2026-2031)

Table 23. Global AI Drug Development Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global AI Drug Development Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global AI Drug Development Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global AI Drug Development Sales Value by Region (2020-2025) & (%)

Table 27. Global AI Drug Development Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions AI Drug Development Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions AI Drug Development Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions AI Drug Development Sales Value, (2026-2031) & (US$ Million)

Table 31. Insilico Medicine Basic Information List

Table 32. Insilico Medicine Description and Business Overview

Table 33. Insilico Medicine AI Drug Development Products, Services and Solutions

Table 34. Revenue (US$ Million) in AI Drug Development Business of Insilico Medicine (2020-2025)

Table 35. Insilico Medicine Recent Developments

Table 36. Cyclica Basic Information List

Table 37. Cyclica Description and Business Overview

Table 38. Cyclica AI Drug Development Products, Services and Solutions

Table 39. Revenue (US$ Million) in AI Drug Development Business of Cyclica (2020-2025)

Table 40. Cyclica Recent Developments

Table 41. XtalPi Inc. Basic Information List

Table 42. XtalPi Inc. Description and Business Overview

Table 43. XtalPi Inc. AI Drug Development Products, Services and Solutions

Table 44. Revenue (US$ Million) in AI Drug Development Business of XtalPi Inc. (2020-2025)

Table 45. XtalPi Inc. Recent Developments

Table 46. Exscientia Limited Basic Information List

Table 47. Exscientia Limited Description and Business Overview

Table 48. Exscientia Limited AI Drug Development Products, Services and Solutions

Table 49. Revenue (US$ Million) in AI Drug Development Business of Exscientia Limited (2020-2025)

Table 50. Exscientia Limited Recent Developments

Table 51. AiCure, LLC Basic Information List

Table 52. AiCure, LLC Description and Business Overview

Table 53. AiCure, LLC AI Drug Development Products, Services and Solutions

Table 54. Revenue (US$ Million) in AI Drug Development Business of AiCure, LLC (2020-2025)

Table 55. AiCure, LLC Recent Developments

Table 56. Atomwise Basic Information List

Table 57. Atomwise Description and Business Overview

Table 58. Atomwise AI Drug Development Products, Services and Solutions

Table 59. Revenue (US$ Million) in AI Drug Development Business of Atomwise (2020-2025)

Table 60. Atomwise Recent Developments

Table 61. Biovista Inc. Basic Information List

Table 62. Biovista Inc. Description and Business Overview

Table 63. Biovista Inc. AI Drug Development Products, Services and Solutions

Table 64. Revenue (US$ Million) in AI Drug Development Business of Biovista Inc. (2020-2025)

Table 65. Biovista Inc. Recent Developments

Table 66. Breg，Inc. Basic Information List

Table 67. Breg，Inc. Description and Business Overview

Table 68. Breg，Inc. AI Drug Development Products, Services and Solutions

Table 69. Revenue (US$ Million) in AI Drug Development Business of Breg，Inc. (2020-2025)

Table 70. Breg，Inc. Recent Developments

Table 71. Numerate Basic Information List

Table 72. Numerate Description and Business Overview

Table 73. Numerate AI Drug Development Products, Services and Solutions

Table 74. Revenue (US$ Million) in AI Drug Development Business of Numerate (2020-2025)

Table 75. Numerate Recent Developments

Table 76. Cloud Pharmaceuticals Basic Information List

Table 77. Cloud Pharmaceuticals Description and Business Overview

Table 78. Cloud Pharmaceuticals AI Drug Development Products, Services and Solutions

Table 79. Revenue (US$ Million) in AI Drug Development Business of Cloud Pharmaceuticals (2020-2025)

Table 80. Cloud Pharmaceuticals Recent Developments

Table 81. IBM Basic Information List

Table 82. IBM Description and Business Overview

Table 83. IBM AI Drug Development Products, Services and Solutions

Table 84. Revenue (US$ Million) in AI Drug Development Business of IBM (2020-2025)

Table 85. IBM Recent Developments

Table 86. NuMedii Basic Information List

Table 87. NuMedii Description and Business Overview

Table 88. NuMedii AI Drug Development Products, Services and Solutions

Table 89. Revenue (US$ Million) in AI Drug Development Business of NuMedii (2020-2025)

Table 90. NuMedii Recent Developments

Table 91. BenevolentAI Basic Information List

Table 92. BenevolentAI Description and Business Overview

Table 93. BenevolentAI AI Drug Development Products, Services and Solutions

Table 94. Revenue (US$ Million) in AI Drug Development Business of BenevolentAI (2020-2025)

Table 95. BenevolentAI Recent Developments

Table 96. Lam Therapeutics Basic Information List

Table 97. Lam Therapeutics Description and Business Overview

Table 98. Lam Therapeutics AI Drug Development Products, Services and Solutions

Table 99. Revenue (US$ Million) in AI Drug Development Business of Lam Therapeutics (2020-2025)

Table 100. Lam Therapeutics Recent Developments

Table 101. Key Raw Materials Lists

Table 102. Raw Materials Key Suppliers Lists

Table 103. AI Drug Development Downstream Customers

Table 104. AI Drug Development Distributors List

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

Table 108. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. AI Drug Development Product Picture

Figure 2. Global AI Drug Development Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global AI Drug Development Sales Value (2020-2031) & (US$ Million)

Figure 4. AI Drug Development Report Years Considered

Figure 5. Global AI Drug Development Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by AI Drug Development Revenue in 2024

Figure 7. AI Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Drug Design Picture

Figure 9. Drug Synthesis Picture

Figure 10. Other Picture

Figure 11. Global AI Drug Development Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 12. Global AI Drug Development Sales Value Market Share by Type, 2024 & 2031

Figure 13. Product Picture of Tumor

Figure 14. Product Picture of Nervous System

Figure 15. Product Picture of Other

Figure 16. Global AI Drug Development Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 17. Global AI Drug Development Sales Value Market Share by Application, 2024 & 2031

Figure 18. North America AI Drug Development Sales Value (2020-2031) & (US$ Million)

Figure 19. North America AI Drug Development Sales Value by Country (%), 2024 VS 2031

Figure 20. Europe AI Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 21. Europe AI Drug Development Sales Value by Country (%), 2024 VS 2031

Figure 22. Asia Pacific AI Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 23. Asia Pacific AI Drug Development Sales Value by Region (%), 2024 VS 2031

Figure 24. South America AI Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 25. South America AI Drug Development Sales Value by Country (%), 2024 VS 2031

Figure 26. Middle East & Africa AI Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 27. Middle East & Africa AI Drug Development Sales Value by Country (%), 2024 VS 2031

Figure 28. Key Countries/Regions AI Drug Development Sales Value (%), (2020-2031)

Figure 29. United States AI Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 30. United States AI Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 31. United States AI Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 32. Europe AI Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 33. Europe AI Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 34. Europe AI Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 35. China AI Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 36. China AI Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 37. China AI Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 38. Japan AI Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 39. Japan AI Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 40. Japan AI Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 41. South Korea AI Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 42. South Korea AI Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 43. South Korea AI Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 44. Southeast Asia AI Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 45. Southeast Asia AI Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 46. Southeast Asia AI Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 47. India AI Drug Development Sales Value, (2020-2031) & (US$ Million)

Figure 48. India AI Drug Development Sales Value by Type (%), 2024 VS 2031

Figure 49. India AI Drug Development Sales Value by Application (%), 2024 VS 2031

Figure 50. AI Drug Development Industrial Chain

Figure 51. AI Drug Development Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global AI Drug Development market? zhanKai

The top companies in the global AI Drug Development market are Insilico Medicine、Cyclica、XtalPi Inc..

Related Reports

AI Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Drug Development was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 112
USD 3950.00
(Single User License)
Global AI Drug Development Market Research Report 2026
The global AI Drug Development market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 114
USD 2900.00
(Single User License)
Global AI Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Drug Development market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 141
USD 4900.00
(Single User License)
Global AI Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI Drug Development market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 95
USD 4250.00
(Single User License)
Global AI Drug Development Market Research Report 2025
The global market for AI Drug Development was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 81
USD 2900.00
(Single User License)
Global AI Drug Development Market Insights, Forecast to 2030
Market Analysis and Insights: Global AI Drug Development Market
Published Date: 2024-04-08
Pages: 111
USD 4900.00
(Single User License)
AI Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI Drug Development was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-22
Pages: 114
USD 3950.00
(Single User License)
Global AI Drug Development Market Research Report 2024
The global AI Drug Development market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 87
USD 2900.00
(Single User License)

AI Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Drug Development was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 112
USD 3950.00 (Single User License)
Global AI Drug Development Market Research Report 2026
The global AI Drug Development market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 114
USD 2900.00 (Single User License)
Global AI Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Drug Development market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 141
USD 4900.00 (Single User License)
Global AI Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI Drug Development market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 95
USD 4250.00 (Single User License)
Global AI Drug Development Market Research Report 2025
The global market for AI Drug Development was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 81
USD 2900.00 (Single User License)
Global AI Drug Development Market Insights, Forecast to 2030
Market Analysis and Insights: Global AI Drug Development Market
Published: 2024-04-08
Pages: 111
USD 4900.00 (Single User License)
AI Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI Drug Development was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-22
Pages: 114
USD 3950.00 (Single User License)
Global AI Drug Development Market Research Report 2024
The global AI Drug Development market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 87
USD 2900.00 (Single User License)